Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (4)
Journal Articles (2)

Journal

Investigative Ophthalmology & Visual Science (6)

Article Type

ARVO Annual Meeting Abstract (4)
Retina (1)
Retinal Cell Biology (1)

Topics

Eye Anatomy and Disorders (2)
Genetics (2)
Retina (2)
Imaging (1)
Multidisciplinary Ophthalmic Imaging (1)
Oncology (1)
Pharmacology (1)
Retinal Cell Biology (1)

Tags

mice (2)
aflibercept (1)
angiogenesis (1)
fatty acid-binding proteins (1)
natural products (1)
neovascularization, pathologic (1)
retina (1)
vascular endothelial growth factor a (1)

Specify Date Range

From: To: Apply

Showing 1 – 6 of 6

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

The role of a novel regulator of Wnt signalling in ocular angiogenesis

Beiying Qiu; Alison Tan; Veluchamy A Barathi; Sze Yuan Ho; Zhou Lei; Ning Cheung; Gemmy Cheung; Tien Yin Wong; Wanjin Hong; Xiaomeng Wang

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4443. doi:

Retina July 2019

Apratoxin S4 Inspired by a Marine Natural Product, a New Treatment Option for Ocular Angiogenic Diseases

PDF

Beiying Qiu; Alison Tan; Amutha Barathi Veluchamy; Yong Li; Hannah Murray; Wei Cheng; Chenghao Liu; Joanna Marie Busoy; Qi-Yin Chen; Srivani Sistla; Walter Hunziker; Chui Ming Gemmy Cheung; Tien Yin Wong; Wanjin Hong; Hendrik Luesch; Xiaomeng Wang
TAGS: angiogenesis, mice, natural products, aflibercept, neovascularization, pathologic, vascular endothelial growth factor a
Invest. Ophthalmol. Vis. Sci.. 2019; 60(8):3254-3263. doi: https://doi.org/10.1167/iovs.19-26936

Includes: Supplemental Content

ARVO Annual Meeting Abstract September 2016

ITF2357 inhibits NF-kB signaling pathway to regulate barrier integrity in retinal pigment epithelial cells

Shyam S Chaurasia; Rayne Ruiyi Lim; Milan N Mehta; Alison Tan; Walter Hunziker; Xinyi Su; Charanjit Kaur; Arkasubhra Ghosh; Veluchamy A Barathi

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1107. doi:

Retinal Cell Biology June 2016

Characterization of Fatty Acid Binding Protein 7 (FABP7) in the Murine Retina

PDF

Xinyi Su; Queenie S. W. Tan; Bhav H. Parikh; Alison Tan; Milan N. Mehta; Yeo Sia Wey; Sai Bo Bo Tun; Ling-Jun Li; Xiao-Yan Han; Tien Y. Wong; Walter Hunziker; Chi D. Luu; Yuji Owada; Veluchamy A. Barathi; Samuel S. Zhang; Shyam S. Chaurasia
TAGS: fatty acid-binding proteins, mice, retina
Invest. Ophthalmol. Vis. Sci.. 2016; 57(7):3397-3408. doi: https://doi.org/10.1167/iovs.15-18542

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2015

ITF2357, a histone deacetylase inhibitor protects barrier function in polarized ARPE-19 cells

Shyam S Chaurasia; Rayne Lim; Milan Mehta; Alison Tan; Arkasubhra Ghosh; Walter Hunziker; Veluchamy A Barathi

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2037. doi:

ARVO Annual Meeting Abstract June 2013

ITF2357 regulates IL-10 via JAK/STAT signaling pathway to attenuate inflammation and fibrosis

Shyam Chaurasia; Yu-Chi Liu; Alison Tan; Rayne Lim; Jodhbir Mehta

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):117. doi:

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2015 Association for Research in Vision and Ophthalmology.

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept